Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antipsychotics: the present status

J Gerlach1, L Peacock

  • 1Department P, St. Hans Hospital, Roskilde, Denmark.

International Clinical Psychopharmacology
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymphoma in two wild tawny frogmouths (Podargus strigoides) in Victoria.

Australian veterinary journal·2024
Same author

THE MIDLATITUDE CONTINENTAL CONVECTIVE CLOUDS EXPERIMENT (MC3E).

Bulletin of the American Meteorological Society·2020
Same author

Improved method for MR microscopy of brain tissue cultured with the interface method combined with Lenz lenses.

Magnetic resonance imaging·2018
Same author

Ultrafast X-Ray Diffraction Studies of the Phase Transitions and Equation of State of Scandium Shock Compressed to 82 GPa.

Physical review letters·2017
Same author

Campylobacter Species and Neutrophilic Inflammatory Bowel Disease in Cats.

Journal of veterinary internal medicine·2016
Same author

Hypersensitivity pneumonitis and antigen identification--An alternate approach.

Respiratory medicine·2016
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

International clinical psychopharmacology·2026
Same journal

Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

International clinical psychopharmacology·2026
Same journal

Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
See all related articles

Classifying antipsychotics by receptor binding and side effects is most effective. This pharmacological-clinical approach categorizes new drugs into dopamine antagonists, dopamine-serotonin-norepinephrine antagonists, and multireceptor antagonists.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Current antipsychotic classification lacks differentiation in psychic function effects.
  • A combined pharmacological-clinical approach offers a more fruitful classification system.

Purpose of the Study:

  • To propose a classification system for antipsychotics based on receptor-binding profiles and side effects.
  • To categorize novel antipsychotic medications based on their pharmacological actions.

Main Methods:

  • Analysis of receptor-binding profiles of antipsychotic drugs.
  • Correlation of receptor-binding data with observed clinical side effects.
  • Categorization of antipsychotics into distinct pharmacological groups.

Main Results:

Related Experiment Videos

  • Antipsychotics are classified into three main categories: pure D2 antagonists, D2-5-HT2-alpha 1 antagonists, and multireceptor antagonists.
  • Clozapine remains a potent antipsychotic with minimal extrapyramidal symptoms.
  • Newer agents like olanzapine, seroquel, and sertindole build upon clozapine's profile, while risperidone and ziprasidone emphasize D2 blockade.

Conclusions:

  • A receptor-binding and side-effect-based classification provides a practical framework for understanding and utilizing antipsychotics.
  • This classification aids both clinicians and pharmacologists in drug selection and research.
  • Novel antipsychotics demonstrate varied receptor interaction profiles, offering diverse therapeutic potentials.